6,834 reports of this reaction
4.7% of all PEGFILGRASTIM reports
#4 most reported adverse reaction
DEVICE MALFUNCTION is the #4 most commonly reported adverse reaction for PEGFILGRASTIM, manufactured by Amgen, Inc. There are 6,834 FDA adverse event reports linking PEGFILGRASTIM to DEVICE MALFUNCTION. This represents approximately 4.7% of all 146,341 adverse event reports for this drug.
Patients taking PEGFILGRASTIM who experience device malfunction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE MALFUNCTION is moderately reported among PEGFILGRASTIM users, representing a notable but not dominant share of adverse events.
In addition to device malfunction, the following adverse reactions have been reported for PEGFILGRASTIM:
The following drugs have also been linked to device malfunction in FDA adverse event reports:
DEVICE MALFUNCTION has been reported as an adverse event in 6,834 FDA reports for PEGFILGRASTIM. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE MALFUNCTION accounts for approximately 4.7% of all adverse event reports for PEGFILGRASTIM, making it a notable side effect.
If you experience device malfunction while taking PEGFILGRASTIM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.